Picture of BioForce Nanosciences Holdings logo

BFNH BioForce Nanosciences Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapNeutral

Annual cashflow statement for BioForce Nanosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.502-0.486-0.472-0.49-1.29
Non-Cash Items00.802
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4240.4170.4250.4290.425
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.078-0.068-0.047-0.061-0.065
Other Investing Cash Flow Items0000
Other Investing Cash Flow
Cash from Investing Activities0000
Financing Cash Flow Items0.0490.0580.0470.0610.065
Other Financing Cash Flow
Cash from Financing Activities0.0490.0580.0470.0610.065
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.029-0.01-00-0